Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Biosensor Detects Extremely Low Bacteria Concentrations

By LabMedica International staff writers
Posted on 04 Aug 2009
A novel carbon-nanotube based potentiometric biosensor is able to detect extremely low concentrations of microorganisms quickly, easily, and reliably. More...


The new biosensor, developed by researchers at the Universitat Rovira i Virgili (Tarragona, Spain) is able to detect ultralow concentrations of bacteria with the aid of specific aptamer sensors. Electrochemical measurements of test solutions are carried out by means of carbon nanotubes that are equipped with bacteria-specific aptamers that serve as binding sites.

The aptamers are anchored the to carbon nanotubes by means of additional functional groups, which are then deposited onto an electrode in an ultrathin layer. In the absence of bacteria, the aptamers fit closely against the walls of the carbon nanotubes. But when the biosensor is put into a specific microorganism-containing sample, the microbes stick to the aptamers; this adhesion influences the interaction between the aptamers and the nanotubes, changing the electrode voltage within seconds. When using the new biosensor, equipped with specific aptamers for Salmonella typhi, the researchers were able to detect extremely low concentrations of the typhus-inducing bacteria. In fact, the researchers were able to detect a bacterial concentration equivalent to 1 Salmonella bacterium in five milliliters of medium, and quantitative measurements were possible down to a low concentration of about 1,000 Salmonella per milliliter. The novel biosensor was described in the July 2009 issue of the journal Angewandte Chemie.

"This biosensor is specific; it does not react to bacteria other than Salmonella typhi,” said study authors Jordi Riu and F. Xavier Rius, of the department of analytic and organic chemistry. "Our new technique makes the detection of microorganisms as fast and simple as the measurement of pH value.”

Aptamers are synthetic short DNA or RNA strands that can be designed and made to bind a specific target molecule. They are composed of oligonucleic acid or peptide molecules that can be used for both basic research and clinical purposes as macromolecular drugs. Aptamers can be also be combined with ribozymes to self-cleave in the presence of their target molecule.

Related Links:

Universitat Rovira i Virgili



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.